Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BIO-key Intl Q2 EPS $(1.00) Up From $(4.71) YoY, Sales $1.14M Down From $1.93M YoY

Author: Benzinga Newsdesk | August 14, 2024 04:31pm
BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(1.00) per share. This is a 78.77 percent increase over losses of $(4.71) per share from the same period last year. The company reported $1.14 million in sales this quarter. This is a 40.83 percent decrease over sales of $1.93 million the same period last year.

Posted In: BKYI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist